These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bronchopulmonary carcinoid tumors--a significant diagnostic problem. Kedra P, Jeleń M, Szkudlarek-Gruszczyńska T, Leśkow E. Rocz Akad Med Bialymst; 1997; 42 Suppl 1():146-61. PubMed ID: 9337533 [Abstract] [Full Text] [Related]
4. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†. Filosso PL, Rena O, Guerrera F, Moreno Casado P, Sagan D, Raveglia F, Brunelli A, Welter S, Gust L, Pompili C, Casadio C, Bora G, Alvarez A, Zaluska W, Baisi A, Roesel C, Thomas PA, ESTS NETs-WG Steering Committee. Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425 [Abstract] [Full Text] [Related]
15. Biology and novel therapeutics for neuroendocrine tumors of the lung. Jafri N, Salgia R. J Biol Regul Homeost Agents; 2004 Oct 31; 18(3-4):275-90. PubMed ID: 15786694 [Abstract] [Full Text] [Related]
18. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G, Scarpa A, Puppa G, Veronesi G, Spaggiari L, Pasini F, Maisonneuve P, Iannucci A, Arrigoni G, Viale G. Cancer; 2005 Mar 15; 103(6):1154-64. PubMed ID: 15712207 [Abstract] [Full Text] [Related]
19. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung. Wolin EM. Chest; 2017 May 15; 151(5):1141-1146. PubMed ID: 27373769 [Abstract] [Full Text] [Related]
20. Systemic therapy for pulmonary carcinoids. Marquez-Medina D, Popat S. Lung Cancer; 2015 Nov 15; 90(2):139-47. PubMed ID: 26371699 [Abstract] [Full Text] [Related] Page: [Next] [New Search]